All latency reversing agents articles
-
NewsAstragalus polysaccharide-linked exosomes “wake up” latent HIV-1 by flipping a key cellular switch
“Shock-and-kill” strategies aim to reactivate latent virus so infected cells become visible to immune clearance or additional therapies. In a new study, researchers investigated whether exosomes could mediate HIV latency reversal after exposure to Astragalus polysaccharide (APS).
-
NewsScientists discover key protein that enables ‘shock & kill’ strategy for HIV latent virus clearance
Researchers have identified a specific gene transcription factor, BRD9, as a potential key to unlocking the mechanisms behind HIV-1 latency.
-
NewsReactivation compound could be latest weapon against HIV
A research team has identified a molecular compound that activates latent HIV-1 in cells, showing promise for HIV treatments.